|
⚲
|
| Keyboard |
| Sabzevari Helen
✚
|
|
|---|---|
| CIK # | 0001724195 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001724195] | |
| 4 | [0001724195] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sabzevari Helen | |
| Precigen Inc | |
| Kinnate Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2026-03-18 | Option exercise | 321,100 | $0.00 | |
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2026-03-18 | Grant | 321,100 | $0.00 | |
|
Precigen Inc PGEN
Common Stock
|
2026-03-18 | Option exercise | 321,100 | ||
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2025-06-26 | Grant | 500,000 | $0.00 | |
|
Precigen Inc PGEN
Option to Purchase Common Stock (Right to Buy) · derivative
|
2025-05-23 | Grant | 1,000,000 | $0.00 | |
|
Precigen Inc PGEN
Common Stock
|
2025-05-16 | Option exercise | 1,079,137 | ||
|
Precigen Inc PGEN
Common Stock
|
2025-05-16 | Tax withheld | 521,224 | $1.45 | 755,775 |
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2025-05-16 | Option exercise | 1,079,137 | $0.00 | |
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2025-04-17 | Grant | 1,079,137 | $0.00 | |
|
Precigen Inc PGEN
Common Stock
|
2025-01-29 | Tax withheld | 286,967 | $1.30 | 373,057 |
|
Precigen Inc PGEN
Common Stock
|
2025-01-29 | Grant | 825,000 | $0.00 | |
|
Precigen Inc PGEN
Option to Purchase Common Stock (Right to Buy) · derivative
|
2024-05-31 | Grant | 1,803,000 | $0.00 | |
|
Precigen Inc PGEN
Common Stock
|
2024-04-05 | Tax withheld | 410,357 | $1.40 | 574,500 |
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2024-04-05 | Grant | 1,071,429 | $0.00 | |
|
Precigen Inc PGEN
Restricted Stock Units · derivative
|
2024-04-05 | Option exercise | 1,071,429 | $0.00 | |
|
Precigen Inc PGEN
Common Stock
|
2024-04-05 | Option exercise | 1,071,429 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 25,000 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 40,501 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 20,250 | ||
|
Precigen Inc PGEN
Common Stock
|
2023-08-25 | Sell | 76,969 | $1.53 | 117,763 |
| showing 20 of 114 most recent transactions | |||||